Assessing feasibility, compliance and toxicity of concomitant chemo-radiotherapy in head and neck cancers in the Northern Territory: initial experience and challenges

Author:

Gupta Ajay12,Baxi Siddhartha34,Hoyne Christopher45

Affiliation:

1. Medical Oncology; Asian Cancer Centre; New Delhi India

2. Medical Oncology; Royal Darwin Hospital; Tiwi Northern Territory Australia

3. Radiation Oncology; South West Radiation Oncology Service; Bunbury Western Australia Australia

4. Radiation Oncology; NTRO; Alan Walker Cancer Centre; Royal Darwin Hospital; Northern Territory Australia

5. Ballarat Regional Integrated Cancer Centre; Ballarat Victoria Australia

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Reference20 articles.

1. Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: The University of Wisconsin experience;Traynor;Head Neck,2010

2. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

3. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemo radiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

4. Evaluation of early and late toxicities in chemoradiation trials;Bentzen;J Clin Oncol,2007

5. Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): An update;Pignon;Int J Radiat Oncol Biol Phys,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3